The table below shows Aligos Therapeutics, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$2.19M
$3.61M
$6.19M
$0.00
$0.00
$0.00
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$69.45M
$70.27M
$73.04M
$85.08M
$104.15M
$79.89M
SG&A
$20.72M
ALGS annual revenue (10-K history)
Aligos Therapeutics, Inc. reported annual revenue of $2.19M for fiscal year 2025. That is down 39.5% from $3.61M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.